Sernova Corp. | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Sernova Corp.

BRIEF

published on 09/27/2024 at 12:47, 1 month 24 days ago

Sernova Corp: First Berlin Equity Research Maintains Buy Rating

BUY Rating Sernova Corp Clinical Trial Type 1 Diabetes Cell Pouch
PRESS RELEASE

published on 09/27/2024 at 12:42, 1 month 24 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Sernova Corp (ISIN: CA81732W1041) with updated price target of CAD1.90 following positive results in treating type 1 diabetes

First Berlin Equity Research BUY Rating Sernova Corp Type 1 Diabetes CAD1.90
PRESS RELEASE

published on 02/06/2024 at 15:02, 9 months 14 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has reiterated its BUY rating and CAD 3.80 price target for Sernova Corp (ISIN: CA81732W1041) based on the company's financial statement release and business update for FY 22/23. Sernova's achievements in diabetes treatment and potential partnering deal are anticipated to drive stock performance

First Berlin Equity Research Sernova Corp FY 22/23 Diabetes Treatment Partnering Deal
PRESS RELEASE

published on 10/19/2023 at 15:57, 1 year 1 month ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): BUY
PRESS RELEASE

published on 09/14/2023 at 22:06, 1 year 2 months ago

Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
PRESS RELEASE

published on 09/13/2023 at 13:01, 1 year 2 months ago

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
PRESS RELEASE

published on 05/03/2023 at 13:01, 1 year 6 months ago

Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
PRESS RELEASE

published on 04/10/2023 at 13:05, 1 year 7 months ago

Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
PRESS RELEASE

published on 03/22/2023 at 12:04, 1 year 7 months ago

Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions
PRESS RELEASE

published on 03/14/2023 at 12:05, 1 year 8 months ago

Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit

Accesswire

Published on 11/21/2024 at 14:15, 16 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 31 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 31 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 31 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 31 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 14 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 16 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 31 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 15 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 55 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 33 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 11 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE